User Stats

Rank: 1393
Karma Score: 114
Joined: March 16, 2023
Submitted Stories: 79
Published Stories: 0
Comments: 0
Votes: 79
Group Name
Membership unavailable

Following

No Following!

Followers

No Follower!

Stories

AITech Interview with Hanjo Kim, SVP of Global Strategy, Head of Medicinal Chemistry at Standigm

Much of the historical progress has been led by AI-native drug discovery companies that offer software or service to pharma players. And facilitating such services by one-of-a-kind organic chemists having expertise in molecular modeling combined with the knowledge of AI can only bring about disruption. So is this inspiring interview with Hanjo Kim, SVP of Global Strategy, Head of Medicinal Chemistry at Standigm.  He believes that AI has the potential to propagate to other intersections of different expertise and improve the overall productivity in drug discovery. To learn more kindly go through the interview highlights below: Please brief our audience about yourself and your role as the SVP of Global Strategy, Head of Medicinal Chemistry at Standigm. I’m an organic chemist by training and education. I have worked for various organizations, a non-profit research organization, a biotech, and a pharmaceutical company, before joining Standigm in 2019. I led the development of Standigm BEST, its chemistry technology, until 2021. From 2022, my role has changed to half research, head of medicinal chemistry, and the other half business development.